
Solisky Pharmaceuticals Private Limited
About Solisky Pharmaceuticals Private Limited
Data last updated:
Solisky Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 13 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2021PTC125555.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ravi Dineshkumar Bhavsar and Darshan Navinchandra Jani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.32 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹7,212 (net margin -0.1%) and EBITDA of ₹1.7 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years.
Solisky Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0111309).
Company details
Recognitions & Rankings of Solisky Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-GJ-01-0111309
Contact details
Solisky Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered Address303 Block – F/1 Tps – 14, Sumel – 11 Indian Textile Plaza Sub Plot No. 17 Tps No. 14, Ahmedabad, Gujarat, India – 380004
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Solisky Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Solisky Pharmaceuticals Private Limited, buy the company report.
Financials of Solisky Pharmaceuticals Private Limited
FY 2025 filings availableSolisky Pharmaceuticals Private Limited reported revenue of ₹73.32 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 50%. EBITDA rose 207% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.7 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹7,212 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.3% | |||
| Net Profit Margin | -0.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Solisky Pharmaceuticals Private Limited, buy the company report.
Board of directors of Solisky Pharmaceuticals Private Limited
Solisky Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Dineshkumar Bhavsar | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
| Darshan Navinchandra Jani Also directs: Medchoice Healthcare Private Limited | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
| Krunal Ashokbhai Thakor Also directs: Medchoice Healthcare Private Limited | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
| Yash Bhavsar Also directs: Medchoice Healthcare Private Limited | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Solisky Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solisky Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Solisky Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Solisky Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Darshan Navinchandra Jani was appointed as Director on 13 Sep 2021.
Frequently asked questions
Solisky Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 13 September 2021 (5+ years old) and is registered under CIN U24290GJ2021PTC125555.
Solisky Pharmaceuticals has 4 current directors:
- Ravi Dineshkumar Bhavsar - Director
- Darshan Navinchandra Jani - Director
- Krunal Ashokbhai Thakor - Director
- Yash Bhavsar - Director
The latest financial statements of Solisky Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Solisky Pharmaceuticals is U24290GJ2021PTC125555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solisky Pharmaceuticals was incorporated on 13 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Darshan Navinchandra Jani was appointed as Director on 13 Sep 2021. Krunal Ashokbhai Thakor was appointed as Director on 13 Sep 2021. Ravi Dineshkumar Bhavsar was appointed as Director on 13 Sep 2021. Solisky Pharmaceuticals has 4 board changes on record in total.
Yes, Solisky Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Solisky Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0111309).
The registered office of Solisky Pharmaceuticals is at 303 Block – F1 Tps – 14, Sumel – 11 Indian Textile Plaza Sub Plot No. 17 Tps No. 14, Ahmedabad, Gujarat, India – 380004.
Solisky Pharmaceuticals operates in the chemicals and materials industry, in the industrial chemicals segment.

